Unclaimed Scholar Profile
Are you Penny L. Moore? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at National Health Laboratory ServiceASIDASID-4847-9078-2421 orcid.org/0000-0001-8719-4028
Penny L. Moore
National Health Laboratory Service
Faculty researcher at National Health Laboratory Service (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#HIV Research and Treatment#SARS-CoV-2 and COVID-19 Research#Monoclonal and Polyclonal Antibodies Research#HIV/AIDS Research and Interventions
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 14,812 | 7,110 |
| h-index | 57 | 43 |
| i10-index | 144 | 101 |
Annual Citation Growth
Verified Citations / Year0
2020711
2021+40%995
2022+29%1.3k
2023+33%1.7k
2024-8%1.6k
2025-45%853
2026Scholarship Distribution & Proportions259 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:25% African Regional Citations (3,703) • 75% Global Research Impact (11,109)
259 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (259)
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Published in Nature•2021
DOI: 10.1038/s41586-021-04387-1 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Published in Nature Medicine•2021
DOI: 10.1038/s41591-021-01285-x Verified Peer-Reviewed
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Published in Nature•2014
DOI: 10.1038/nature13036 Verified Peer-Reviewed
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Published in Nature•2022
DOI: 10.1038/s41586-022-04460-3 Verified Peer-Reviewed
Showing 1 – 5 of 259 publications
1 / 52